In support of driving innovation in radiology technology, GE Healthcare is investing in early-stage research focused on moving the needle for clinicians and patients.
Healthcare, like many industries, is in constant pursuit of innovation to make processes and technologies more efficient, reduce costs, and improve consumer experience.
Unlike many industries, healthcare has the unique opportunity to source ideas from innovators worldwide to advance existing technologies and discover new solutions with research partnerships and investment.
Cutting-edge technologies, along with advanced research, are among some of the highest priorities for Healthcare systems not only here in the United States, but worldwide. A united mission of finding the most advanced therapies and state-of-the-art diagnostic tools are driving the future of investing in medical technologies.
In 2016, the medical device industry was valued at an $147.7 billion in the U.S. alone and is projected to grow to $173 billion in 2019. The rapid growth doesn’t stop there. Forecasters predict to see growth to be upwards of $208 billion by 2023.
The growth of Radiology is no exception.
Recently, GE Healthcare had the opportunity to recognize and award several researchers with over $350,000 to advance their projects designed to drive the medical imaging and healthcare industries forward. GE Healthcare’s support for the projects is in collaboration with the Radiological Society of North America (RSNA). Recognizing the value and importance of medical research, the collaboration offers the grant awards to emerging leaders in radiology research.
“The RSNA Research and Education Foundation plays a critical role in supporting important research priorities that are vital to the advancement of radiology and it is an important avenue to support future leaders in the field,” said Bram Stolk, PhD, GM Global Research Organization at GE Healthcare. “For those reasons, GE Healthcare is proud to continue our commitment to the R&E Foundation.”
Recipients and projects include:
- Peter Chang, M.D., University of California, Irvine, will leverage deep learning through convolutional neural networks (CNNs), a subset of machine learning and artificial intelligence, to improve CT interpretation time for patients with suspected acute ischemic strokes, reliably quantify the extent of ischemic core defined by ASPECTS from CT imaging in the acute setting, and accurately quantify the extent of viable tissue from CT perfusion data. Dr. Chang’s research could potentially advance stroke imaging capabilities by establishing a superior approach to ischemic stroke triage while also providing reliable and accurate measures of ischemic and viable tissue.
- Nima Kokabi, M.D., Emory University School of Medicine, with scientific advisor, David Schuster, M.D., will investigate the theranostic use of low-dose Y90 for accurate treatment planning in patients with hepatocellular carcinoma undergoing Y90 radioembolization. This novel technique could ultimately improve the accuracy of personalized treatment planning with the overarching goal of improving tumor response and survival while minimizing liver and lung toxicity related to Y90 radioembolization.
- Ali Salavati, M.D., M.P.H., University of Minnesota, with scientific advisors Jerry Froelich, M.D. and Thomas Hope, M.D., will investigate the diagnostic performance and the optimal timing to perform 18FFACBC PET/CT in prostate cancer patients with biochemical recurrence using multivariate modeling of prostatic specific antigen kinetics and clinical/pathological features. These models could potentially be used in the decision support algorithm and will augment appropriate use of 18F-Fluciclovine PETCT/MRI scan by clinicians.
- Justin Tse, M.D., Stanford University, will apply quantitative imaging techniques to multidetector CT angiography for patients presenting with acute gastrointestinal bleeding, in an effort to identify quantitative biomarkers that can triage patients who are more likely to require additional treatment, such as massive transfusion requirements or intervention.
Together, these projects showcase the value of medical research to driving the future of radiology and patient care forward. By supporting research and education, in radiology and other related scientific disciplines through funding grants and awards, we’re able to shape the pathway for these innovative and excited individuals and their institutions and their practice.
To learn more about research and innovation on the floor at this years RSNA, click here.